BioFarma received support from the foundation to expand access to its novel oral poliovirus vaccine type 2 (nOPV2) for the Global Polio Eradication Initiative. Investment Date: April 2022
Program Areas: Polio
Sanofi
The foundation partnered with Sanofi to secure a reduced price for Inactivated Polio Vaccine (IPV).
Beijing Bio-Institute Biological Products
Beijing Bio-Institute Biological Products is devoted to the research, development, production, and supply of biological products.
Press Release: Inactivated Polio Vaccines Broadly Available for the World’s Children in the Drive toward Polio Eradication
Sanofi Pasteur February 28, 2014 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today its further commitment to the international community’s efforts to complete polio eradication. UNICEF, the organization that procures the vaccine to meet Read More
Press Release: UNICEF and Gates Foundation join forces to support Angola’s efforts to eradicate polio
Bill & Melinda Gates Foundation January 21, 2011 The Bill & Melinda Gates Foundation and UNICEF today announced that Mr. Anthony Lake, UNICEF Executive Director, and Dr. Tachi Yamada, president of the Global Health Program of the Gates Foundation, will Read More
Press Release: Tiantan Biological Products receives financial backing from Bill & Melinda Gates Foundation
Research in China November 16, 2011 Beijing Tiantan Biological Products (600161.SH) plans to sign financial aid, loan and unilateral guarantee agreements with the Bill & Melinda Gates Foundation to develop oral polio vaccines (OPV), reports stcn.com, citing a company filing. Read More